Neopharma obtains European GMP Approval for Abu Dhabi Facility

Neopharma obtains European GMP Approval for Abu Dhabi Facility

UAE based pharmaceutical company, Neopharma obtained its GMP Certification by the National Authority of Medicines and Health Products (Infarmed), Portugal. The certification was granted following an inspection of its Abu Dhabi facility in January 2018, in line with the EU – GMP directives.

The manufacturing plant was found to be GMP Compliant as per the guidelines laid down by the Directive 2003/94/EC. The EU – GMP Certification was accorded to both manufacturing areas within Neopharma (General Products, Beta Lactams).

The approval, which is valid in the entire European Union along with other PICS markets, will facilitate Neopharma’s entry into European markets along with increasing opportunities in contract manufacturing business. Neopharma currently manufactures general products and Beta – Lactams in capsules (hard shelled), tablets and liquid formulations for internal use.

The EU GMP approval comes in line with Neopharma’s commitment towards providing cost effective, high quality pharmaceutical products. In addition to the EU – GMP, the manufacturing facility at Neopharma is also compliant as per UAE MOH GMP guidelines, and ISO certifications including ISO 9001, ISO 14001 and ISO 180001.